EBLF Health+Benefits

Podcast: DNA’s Day in Employee Benefits

Leader’s Edge sat down with Wamberg Genomic Advisors’ (WGA) Chief Innovation Officer, Darren Rowe, to talk about the innovation propelling WGA and how genomics promotes a more holistic view of patient health.
By Katie Oberkircher Posted on May 13, 2020

We caught up with WGA’s Chief Innovation Officer, Darren Rowe, after the onset of the coronavirus to learn more about how WGA reshaped its Cancer Guardian solution to support one of the most vulnerable populations during this pandemic.

Q
Tell me about WGA’s response to COVID-19.
A
We recognized fairly quickly that the implications of COVID-19 could be severe and devastating not just from a health perspective but financially and emotionally. Our colleagues in the medical and science community did a good job keeping us updated and we were fortunate to be able to act quickly. We built our company on a strong digital foundation so we were able to deploy a WFH strategy with minimum disruption. We were also able to repurpose our cancer financial navigation program to help our members access COVID-19 financial assistance. New programs and foundations are being set up every day to help people with the financial challenges this pandemic presents and many are aimed at those with other underlying health conditions (not just cancer).
Q
Routine preventive screenings such as mammograms and colonoscopies have for the most part been tabled as the coronavirus crisis worsens. Now as states look to ease stay-at-home restrictions, physicians are anticipating their clinics will see an influx of new cancer diagnoses and potentially worse prognoses. What does that mean for the cancer community?
A
Routine preventive screenings such as mammograms and colonoscopies have for the most part been tabled as the coronavirus crisis worsens. Now as states look to ease stay-at-home restrictions, physicians are anticipating their clinics will see an influx of new cancer diagnoses and potentially worse prognoses. What does that mean for the cancer community?

Listen to the podcast here.

Katie Oberkircher Director, Market Intelligence & Insights Read More

More in EBLF

Teeing Up Our Conversation with Charlie Cook
EBLF Teeing Up Our Conversation with Charlie Cook
From Senate races to single payer healthcare, we asked our Government Affairs te...
EBLF The Crisis Inside
Mental health issues may be hard to see, but now more than ever they need employ...
EBLF Like You've Never Seen Before
EBLF EBLF Like You've Never Seen Before
The Council is launching a month-long thought leadership campaign focused on emp...
Telemedicine’s Triple Risk
EBLF Telemedicine’s Triple Risk
Q&A with Jennifer Schoenthal, Miscellaneous Medical Underwri...
Medical Exam
EBLF Medical Exam
Tech-enabled transparency is a major step in regaining contr...